198 related articles for article (PubMed ID: 314291)
21. [The significance of C3 and C4 of serum complement in systemic lupus erythematosus (SLE)].
Grlickov M
God Zb Med Fak Skopje; 1978; 24():323-7. PubMed ID: 757182
[No Abstract] [Full Text] [Related]
22. Systemic lupus erythematosus in childhood correlations between changes in disease activity and serum complement levels.
Singsen BH; Bernstein BH; King KK; Hanson V
J Pediatr; 1976 Sep; 89(3):358-69. PubMed ID: 956959
[TBL] [Abstract][Full Text] [Related]
23. Immunological aspects of biopsy-proven lupus nephritis in Bahraini patients with systemic lupus erythematosus.
Farid EM; Hassan AB; Abalkhail AA; El-Agroudy AE; Arrayed SA; Al-Ghareeb SM
Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1271-9. PubMed ID: 24231503
[TBL] [Abstract][Full Text] [Related]
24. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
[TBL] [Abstract][Full Text] [Related]
25. Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group.
Ricker DM; Hebert LA; Rohde R; Sedmak DD; Lewis EJ; Clough JD
Am J Kidney Dis; 1991 Dec; 18(6):678-85. PubMed ID: 1962653
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus.
Li H; Lin S; Yang S; Chen L; Zheng X
Clin Rheumatol; 2015 Mar; 34(3):471-7. PubMed ID: 25597615
[TBL] [Abstract][Full Text] [Related]
27. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.
Charlesworth JA; Peake PW; Golding J; Mackie JD; Pussell BA; Timmermans V; Wakefield D
Ann Rheum Dis; 1989 Feb; 48(2):153-9. PubMed ID: 2784659
[TBL] [Abstract][Full Text] [Related]
28. Repeat Testing of Antibodies and Complements in Systemic Lupus Erythematosus: When Is It Enough?
Raissi TC; Hewson C; Pope JE
J Rheumatol; 2018 Jun; 45(6):827-834. PubMed ID: 29657153
[TBL] [Abstract][Full Text] [Related]
29. Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Hammond A; Rudge AC; Loizou S; Bowcock SJ; Walport MJ
Arthritis Rheum; 1989 Mar; 32(3):259-64. PubMed ID: 2522783
[TBL] [Abstract][Full Text] [Related]
30. Demonstration of beta 1H globulin together with C3 in the dermal-epidermal junction of patients with systemic lupus erythematosus.
Carlo JR; Rothfield NF; Ruddy S
Arthritis Rheum; 1979 Jan; 22(1):13-8. PubMed ID: 83148
[TBL] [Abstract][Full Text] [Related]
31. Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.
Johnson SR; Khanna D; Daikh D; Cervera R; Costedoat-Chalumeau N; Gladman DD; Hahn BH; Hiepe F; Sánchez-Guerrero J; Massarotti E; Boumpas DT; Costenbader KH; Jayne D; Dörner T; Kamen DL; Mosca M; Ramsey-Goldman R; Smolen JS; Wofsy D; Aringer M
J Rheumatol; 2019 Jul; 46(7):721-726. PubMed ID: 30554156
[TBL] [Abstract][Full Text] [Related]
32. Disease activity in systemic lupus erythematosus. Value of laboratory criteria.
Claudy AL; Touraine JL; Alario A
Clin Exp Dermatol; 1979 Dec; 4(4):435-43. PubMed ID: 317029
[No Abstract] [Full Text] [Related]
33. Predictive value of anti-DNA antibody and selected laboratory studies in systemic lupus erythematosus.
Ludivico CL; Zweiman B; Myers AR; Hebert J; Green PA
J Rheumatol; 1980; 7(6):843-9. PubMed ID: 6970815
[TBL] [Abstract][Full Text] [Related]
34. A comparison of three anti-double stranded DNA antibody assays on sera from SLE and other diseases.
Clarke MC; Carr R; Burdash NM; Chen ZY; Ainsworth SK
Diagn Immunol; 1986; 4(6):288-93. PubMed ID: 3545632
[TBL] [Abstract][Full Text] [Related]
35. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
[TBL] [Abstract][Full Text] [Related]
36. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).
Lloyd W; Schur PH
Medicine (Baltimore); 1981 May; 60(3):208-17. PubMed ID: 7231154
[TBL] [Abstract][Full Text] [Related]
37. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
[TBL] [Abstract][Full Text] [Related]
38. Immunological abnormalities in primary APS evolving into SLE: 6 years follow-up in women with repeated pregnancy loss.
Carbone J; Orera M; Rodríguez-Mahou M; Rodríguez-Pérez C; Sánchez-Ramón S; Seoane E; Rodríguez JJ; Zabay JM; Fernández-Cruz E
Lupus; 1999; 8(4):274-8. PubMed ID: 10413205
[TBL] [Abstract][Full Text] [Related]
39. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
[TBL] [Abstract][Full Text] [Related]
40. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
Garabet L; Gilboe IM; Mowinckel MC; Jacobsen AF; Mollnes TE; Sandset PM; Jacobsen EM
Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
